Teresa Zimmers, professor of cell, developmental and cancer biology at the Oregon Health & Sciences University School of Medicine, at 12:55 p.m. Wednesday, Jan. 29, on Zoom.
Roche has reported positive results from the second year of the EMBARK Phase III trial of Elevidys (delandistrogene moxeparvovec), the first approv ...